期刊文献+

RP-HPLC法测定盐酸托莫西汀的含量和有关物质 被引量:8

Determination of Atomoxetine Hydrochloride and Its Related Substances by RP-HPLC
原文传递
导出
摘要 目的:建立RP-HPLC法测定盐酸托莫西汀的含量和有关物质。方法:采用Kromasil C18(4.6mm×250mm,5μm)色谱柱,流动相:乙腈-水-三乙胺溶液(40:60:0.5,冰醋酸调pH至6.0),流速:1.0mL·min-1,检测波长:270nm,柱温:室温。结果:有关物质与盐酸托莫西汀分离良好,盐酸托莫西汀在2.050.0mg·mL-1范围内线性关系良好(r=0.9998),平均回收率为99.8%(RSD=1.7%),检测限为80μg.L-1(S/N=3)。盐酸托莫西汀与有关物质分离良好。结论:该方法操作简便、重复性好、专属性强,可用于测定盐酸托莫西汀的含量和有关物质。 Objective:To establish a HPLC method for determination the content of atomoxetine hydrochloride and its related substances.Methods:The determination of atomoxetine hydrochloride and the separation of its related substances was performed on a Kromasil C18 column(4.6 mm × 250 mm,5 μm).The mobile phase consisted of acetonitrile-water-triethylamine(40:60:0.5,adjusted pH to 6.0 with acetic acid).The flow rate was 1.0 mL·min-1.Ultraviolet absorption detector was set at 270 nm and column temperature at room temperature.Results:The linearity of atomoxetine hydrochloride was in the range of 2.0 to 50.0 mg·L-1(r= 0.999 8).The average recovery was 99.8 % with RSD of 1.7 %.The related substances of atomoxetine hydrochloride were completely separated from atomoxe-tine hydrochloride.The limit of detection(LOD)was 80 μg·L-1(S/N=3).Conclusions:A reproducible and specific method is provided for the determination of atomoxetine hydrochloride and its related substances
出处 《现代生物医学进展》 CAS 2010年第18期3541-3543,共3页 Progress in Modern Biomedicine
关键词 盐酸托莫西汀 高效液相色谱法 含量测定 有关物质 Atomoxetine Hydrochloride HPLC Quantitative determination Related substances
  • 相关文献

参考文献8

二级参考文献42

  • 1王爱民,周宏博,董钦.肌肽,一种神奇的小肽[J].生命的化学,2004,24(4):314-316. 被引量:7
  • 2杜蕾,马培奇.盐酸托莫西汀及其市场展望[J].中国制药信息,2005,21(7):13-15. 被引量:1
  • 3郭勇,严宏.肌肽预防白内障形成的作用[J].眼科学报,2006,22(2):85-88. 被引量:7
  • 4PUTT K S,CHEN G W,PEARSON J M,et al. Small- molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy [ J ]. Nature Chemical Biology ,2006,2 ( 10 ) :543 - 550.
  • 5Ch.P(2005)Vol Ⅱ(中国药典2005年版.二部附录)[S].2005:Appendix,30.
  • 6Kratochvil CJ, Heligenstein JH, Dittmann R, et al. Atomoxetion and methylphenidate treatment in children with ADHD: a prospective,randomized, open-label trial [J]. J Am Child Adolesc Psychiatry, 2002, 41(7) :776-784.
  • 7Schachter HM, Pham B, King J, et al. How efficacious and safe is shortacting methylphenidate for the treatment of attention-deficit disorder inchildren and adolescents? A meta-analysis[J]. CMAJ, 2001, 165(11):1475-1488.
  • 8Bymaster FP, Katner JS, Nelson DL, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention-deficit/hyperactivity disorder [J].Heuropsychopharmacology, 20
  • 9Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study [J]. Pediatrics, 2001,108(5): E83-86.
  • 10Simpson D, Perry CI.Atomoxetion[J] .Paediatr Drugs,2003,5(6):407-417.

共引文献29

同被引文献49

引证文献8

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部